CVS Health Corporation

CVS · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.1%

Institutions91.0%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$265.08B	$247.76B	$257.43B	$236.30B	$214.78B	$268.71B	$192.64B	$193.92B	$184.76B	$177.53B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$221.17B	$206.29B	$217.10B	$196.89B	$175.80B	$163.98B	$158.72B	$156.45B	$156.22B	$148.67B
Revenue left after subtracting the direct cost of producing goods or services — how efficiently the core business converts sales into profit before overhead.	–	–	–	–	–	–	–	–	$28.55B	$28.86B
Gross profit as a percentage of revenue.	–	–	–	–	–	–	–	–	15.4%	16.3%
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$4.66B	$8.52B	$13.74B	$7.75B	$13.19B	$13.91B	$11.99B	$4.02B	$9.52B	$10.34B
Operating income as a percentage of revenue.	1.8%	3.4%	5.3%	3.3%	6.1%	5.2%	6.2%	2.1%	5.2%	5.8%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$40.00M	-$28.00M	$24.00M	$16.00M	-$12.00M	$13.00M	-$3.00M	-$594.00M	$6.62B	$5.32B
Net income divided by the number of shares outstanding — profit attributable to each share.	$1.40	$3.67	$6.49	$3.00	$6.00	$5.48	$5.10	$0.00	$6.00	$4.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$1.39	$3.66	$6.47	$3.00	$5.95	$5.46	$5.08	$0.00	$6.00	$4.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$8.45B	$8.59B	$8.20B	$12.95B	$9.41B	$7.85B	$5.68B	$4.06B	$1.70B	$3.37B
Everything the company owns that has value — cash, property, inventory, investments, and more.	$253.54B	$253.22B	$249.73B	$228.28B	$233.00B	–	$222.45B	$196.46B	$95.13B	$94.46B
All of the company's interest-bearing borrowings, short and long term combined.	$0	$2.12B	$200.00M	–	–	–	$3.78B	$73.43B	$27.00B	$27.53B
Everything the company owes — debt, unpaid bills, and other obligations.	$178.16B	$177.49B	$173.09B	$156.96B	$157.62B	–	$158.28B	$137.91B	–	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$75.21B	$75.56B	$76.46B	$71.02B	$75.08B	–	$63.86B	$58.23B	$37.69B	$36.83B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$10.64B	$9.11B	$13.43B	$16.18B	$18.27B	$15.87B	$12.85B	$8.87B	$8.01B	$10.07B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$2.83B	$2.78B	$3.03B	$2.73B	$2.52B	$2.44B	$2.46B	$2.04B	$1.92B	$2.22B
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$7.81B	$6.33B	$10.39B	$13.45B	$15.74B	$13.43B	$10.39B	$6.83B	$6.09B	$7.84B

	You	Peer avg
P/E	25.4	21.2
Revenue Growth	+7.1%	+16.8%
ROE	6.2%	14.4%

CVS Health Corporation

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Related Market Insights

S&P 500 Q2 2026 Earnings Deliver Record-Breaking Surprises Driven by Tech Giants

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison